Time for sharp competitive intelligence

Posts tagged ‘lovenox anti-coagulant’

Sanofi-Aventis ‘considering legal options

Sanofi-Aventis said it is ‘considering all its legal options’ after the U.S. Court of Appeals upheld an earlier ruling in the Lovenox anti-coagulant patent infringement suit against Amphastar and Teva Pharmaceutical Industries.

As a result of the Court of Appeals ruling the U.S. Lovenox patent is deemed to be ‘unenforceable’.

While several generic manufacturers have requested marketing approval from the FDA for their products alleged to be generic versions of Lovenox, Sanofi-Aventis has not learned of any FDA approval of these requests.


Tag Cloud